Nalaganje...

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

Pancreatic ductal adenocarcinoma (PDAC), which constitutes 90% of pancreatic cancers, is the fourth leading cause of cancer-related deaths in the world. Due to the broad heterogeneity of genetic mutations and dense stromal environment, PDAC belongs to one of the most chemoresistant cancers. Most of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Adamska, Aleksandra, Domenichini, Alice, Falasca, Marco
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5535831/
https://ncbi.nlm.nih.gov/pubmed/28640192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18071338
Oznake: Označite
Brez oznak, prvi označite!